$TLRY

Canaccord Genuity maintains Hold rating on Tilray Brands, $4 price target

Canaccord Genuity kept a Hold rating on Tilray Brands with a $4 price target, suggesting 11.4% upside from the Oct 8 close. Tilray reported $257.1M revenue, missing estimates due to cannabis segment challenges and international pricing pressures. BrewDog contributed $55.9M to the beverage segment, showing growth.

Original reporting
Published Oct 9, 2026, 5:59 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 9, 2026, 6:10 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Canaccord Genuity maintains Hold rating on Tilray Brands, $4 price target — source image
Decision brief

The 30-second read

$TLRYBearishLow
01

Why it matters

The Hold rating and $4 target imply modest upside, but the revenue miss may trigger sell pressure.

02

Market read

Analyst rating change on a revenue‑missing cannabis stock; modest impact on TLRY and sector peers.

03

What to watch

Potential cost‑cutting measures or upcoming product launches were not discussed but could mitigate revenue shortfall.

Relevance 6/10Novelty 5/10Timing: pre‑market today

Background

Tilray Brands is a US‑listed cannabis company; analyst notes often move the stock on rating changes.

Company-level read

Ticker impact

$TLRYBearishMedium confidence
Context

Canaccord Genuity issued a Hold rating and $4 price target after Tilray reported a revenue miss of $257.1M versus $266.3M consensus.

Expected impact

likely downward pressure as investors price in the lower guidance and rating downgrade

Evidence & confidence

The rating change and sub‑consensus revenue signal weaker near‑term outlook, prompting potential sell‑side activity.

Market effects

Cannabis sector may see broader scrutiny as Tilray's miss highlights pricing pressures.

North American cannabis stocks could face short‑term volatility.

Limited to investors tracking cannabis equities.

Counterpoint

The Hold rating may be overly cautious; the BrewDog contribution suggests upside potential if the segment scales.

Key entities

  • Tilray Brands

    Cannabis producer with ticker TLRY.

  • Canaccord Genuity

    Issued the Hold rating and price target.

Related articles

$TLRYLow

Should you sell your Tilray stock?

Tilray Brands (TSX:TLRY) reported fiscal Q1 2027 revenue of $257.1M and Adjusted EBITDA of $9.2M, missing analyst estimates. Cannabis revenue fell 13% year-over-year, while beverage alcohol revenue rose 82.1%. Analyst Neal Gilmer maintained a 'Hold' rating and $4.00 target, citing concerns about organic growth and cash flow.

$TLRYMed

Tilray Brands revenue rises 20% in Q1 2027

Tilray Brands reported a 20% revenue increase to $257.1M in Q1 2027, driven by beverage sales. Gross profit rose 35% to $77.5M. Beverage revenue grew 82% to $101.5M, while cannabis revenue declined. The company reported a net loss of $40M but reduced debt by $42M. Tilray reaffirmed its adjusted EBITDA guidance of $68M-$75M for the fiscal year.

$TLRYMedAI 8/10

Tilray (TLRY) Q1 2027 Earnings Call Transcript

Tilray (TLRY) reported Q1 2027 revenue of $257 million, up 23% YoY, with expanded gross margins. The company highlighted its global scale, leadership in cannabis, beverage, and wellness, and strategic acquisitions like BrewDog. Tilray emphasized its diversified business model, international growth, and cost reductions in key markets like Portugal and Germany.

$TLRYMedAI 8/10

Tilray Brands Inc (TLRY) (Q1 2027) Earnings Call Highlights: Record Revenue

Tilray Brands Inc (TLRY) reported a Q1 net loss of $40M, down from a $1.5M profit last year, due to higher marketing costs and fuel surcharges. Revenue was impacted by cannabis price compression, supply constraints, and inventory shifts. BrewDog turned profitable, and the company expects continued growth. Tilray also discussed partnerships, international expansion, and potential M&A opportunities.

$TLRYHigh

Tilray Brands swings to $40M loss as revenue rises

Tilray Brands reported a net loss of $40.0 million for Q2 2026, despite revenue growth to $257.1 million. Gross profit rose to $77.5 million, but operating loss was $24.1 million. Cannabis revenue declined, while beverage revenue increased. The company issued shares to repay debt and amended credit agreements to ease covenant testing.